Impaired renal function in acute myocardial infarction

Cardiology Journal

Volumn 16, Issue 5, 2009, Pages 400-406

  Lekston, Andrzej ^a   Kurek, Anna ^a   Tynior, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute myocardial infarction; Contrast induced nephropathy; Impaired renal function

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFUSION FLUID; IODINATED CONTRAST MEDIUM; SIMVASTATIN; SODIUM CHLORIDE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG CONTRAINDICATION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RENAL PROTECTION; REVIEW; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION;

ACUTE DISEASE; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CONTRAST MEDIA; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 70349696882     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Sarnak MJ, Levey AS, Schoolwerth AC et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169.
2. Gibson CM, Pinto DS, Murphy SA et al. Association of creatinine and creatine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol, 2003; 42: 1535-1543.
3. Sørensen CR, Brendorp B, Rask-Madsen C, Kober L, Kjoller E, Torp-Pedersen C. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J, 2002; 23: 948-952.
4. Yamaguchi J, Kasanuki H, Ishii Y et al. Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty. Data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry. Circ J, 2007; 71: 1354-1359.
5. Assali AR, Brosh D, Ben-Dor I et al. The impact of renal insufficiency on patients outcomes in emergent angioplasty for acute myocardial infarction. Cathet Cardiovasc Interv, 2007; 69: 395-400.
6. Holzmann MJ, Hammar N, Ahnve S, Nordqvist T, Pehrsson K, Ivert T. Renal insufficiency and long-term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting. Eur Heart J, 2007; 28: 865-871.
7. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 2003; 361: 13-20.
8. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol, 2004; 44: 1780-1785.
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis, 2002; 39 (2 suppl.): I80-I93.
10. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int, 1997; 51: 1908-1919.
11. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med, 2003; 139: 137-147.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 16: 31-41.
13. Ludbrook J. Statistical techniques for comparing measurers and methods of measurement: a critical review. Clin Exp Pharmacol Physiol, 2002; 29: 527-536.
14. McCullough PA, Stacul F, Becker CR et al. Contrast-induced nephropathy: Clinical insights and practical guidance a report from the CIN consensus working panel. Am J Cardiol Suppl. 2006; 98: 6A.
15. Benko A, Fraser-Hill M, Magner P et al. Canadian Association of Radiologists: Consensus guidelines for the prevention of contrast induced nephropathy. Can Assoc Radiol J, 2007; 58: 79-87.
16. Vasu S, Gruberg L, Brown DL. The Impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Cathet Cardiovasc Interv, 2007; 70: 701-705.
17. Schiffrin EL, Lipman ML, Mann J. Chronic kidney disease: Effects on the cardiovascular system. Circulation, 2007; 116: 85-97.
18. Vanholder R, Massy Z., Argiles A, Spasovski G, Verbeke F, Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant, 2005; 20: 1048-1056.
19. Sarnak MJ, Levey AS, Schoolwerth AC et al. Cardiovascular disease, high blood pressure research, clinical cardiology, and statement from the American Heart Association Councils on Kidney in kidney disease as a risk factor for development of cardiovascular disease: A epidemiology and prevention. Circulation, 2003; 108: 2154-2169.
20. Osten MD., Ivanov J, Eichhofer J et al. Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. Am J Cardiol, 2008; 101: 780-785.
21. Yamaguchi J, Kasanuki H, Ishii Y et al Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol, 2004; 93: 1526-1528.
22. Koganei H, Kasanuki H, Ogawa H, Tsurumi Y. Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction. Circ J, 2008; 72: 179-185.
23. Eijkelkamp WB, de Graeff PA, van Veldhuisen DJ et al. Effect of first myocardial ischemic event on renal function. Am J Cardiol, 2007; 100: 7-12.
24. Latchamsetty R, Fang J, Kline-Rogers E et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am J Cardiol, 2007; 99: 939-942.
25. Kowalczyk J, Lenarczyk R, Kowalski O et al. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol, 2007; 65: 635-643.
26. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol, 2004; 44: 1780-1785.
27. de Werf FW, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J, 2008; 29: 2909-2945.
28. Silber S, Albertsson P, Avile's FF et al. Guidelines for percutaneous coronary interventions the task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J, 2005; 26: 804-847.
29. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet, 2003; 361: 13-20.
30. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med, 2003; 348: 491-499.
31. Masuda M, Yamada T, Mine T et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol, 2007; 100: 781-786.
32. Briguori C, Colombo A, Airoldi F et al. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: Impact of N-acetylcysteine. Kidney Intern, 2005; 68: 2250-2255.
33. Nallamothu BK, Shojania KG, Saint S et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med, 2004; 117: 938-947
34. Briguori C, Airoldi F, D'Andrea D et al. Renal insufficiency following contrast media administration trial. Circulation, 2007; 115; 1211-1217.
35. Kelly AM, Dwamena B, Cronin P, Bemstein SJ, Carlos RC. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med, 2008; 148: 284-294.
36. Chyrchel M, Rakowski T, Rzeszutko L et al. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Kardiol Pol. 2006; 64: 1357-1362.
37. Patti G, Nusca A, Chello M et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol, 2008; 101: 279-285.
38. Zhao JL, Yang YJ, Zhang YH, You SJ, Wu YJ, Gao RL. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty. Int J Cardiol, 2008; 126: 435-436.
39. Jo SH, Koo BK, Park JS et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial: A randomized controlled study. Am Heart J, 2008; 155: 499: e1-e8.
40. Bouzas-Mosquera A, Vázquez-Rodríguez JM. Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures. Am J Cardiol, 2008; 101: 910.